Literature DB >> 20639012

Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence.

Martin M Crane, Cindy Ma Chang, Monica G Kobayashi, Peter F Weller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20639012      PMCID： PMC5781228          DOI： 10.1016/j.jaci.2010.03.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.

Authors:  Amy D Klion; Bruce S Bochner; Gerald J Gleich; Thomas B Nutman; Marc E Rothenberg; Hans-Uwe Simon; Michael E Wechsler; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2006-05-03       Impact factor: 10.793

Review 2.  Approach to the therapy of hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 3.  Hypereosinophilic syndrome: an update.

Authors:  H Jeffrey Wilkins; Martin M Crane; Kelly Copeland; William V Williams
Journal:  Am J Hematol       Date:  2005-10       Impact factor: 10.047

4.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

5.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

Review 6.  Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Authors:  J Gotlib; J Cools
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

Review 7.  Clinical overview of hypereosinophilic syndromes.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479
  7 in total
  37 in total

Review 1.  Eosinophilic myeloproliferative disorders.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Pruritic annular patches with eosinophilia.

Authors:  Doris Weiss; Nikita Lakdawala; Harleen Sidhu; Robert Phelps; Jason Emer
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

3.  FIP1L1-PDGFRA fusion-negative hypereosinophilic syndrome with uncommon cardiac involvement responding to imatinib treatment: A case report.

Authors:  Amanda Santos Dal Berto; Ricardo Hohmann Camiña; Eduardo Silva Machado; Antuani Rafael Baptistella
Journal:  Mol Clin Oncol       Date:  2018-05-21

Review 4.  Eosinophilia in Hematologic Disorders.

Authors:  Lorenzo Falchi; Srdan Verstovsek
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

5.  Loeffler's endocarditis with isolated left ventricular involvement on cardiac MRI.

Authors:  Pramod Kumar; Sheragaru Hanumanthappa Chandrashekhara; Sanjeev Kumar; Amarinder Singh Malhi
Journal:  BMJ Case Rep       Date:  2019-04-20

6.  Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS).

Authors:  Odelya E Pagovich; Katie M Stiles; Anna E Camilleri; Anthony R Russo; Saparja Nag; Ronald G Crystal
Journal:  Leukemia       Date:  2021-09-20       Impact factor: 11.528

7.  Marked and persistent eosinophilia in the absence of clinical manifestations.

Authors:  Yun-Yun K Chen; Paneez Khoury; JeanAnne M Ware; Nicole C Holland-Thomas; Jennifer L Stoddard; Shakuntala Gurprasad; Amy J Waldner; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2013-08-26       Impact factor: 10.793

8.  Acute Eosinophilic Myocarditis and Hyper IgE in HIV Infection: A Case Report.

Authors:  Mohammad Thawabi; Mirette Habib; Hamid Shaaban; Fayez Shamoon
Journal:  N Am J Med Sci       Date:  2014-07

9.  Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study.

Authors:  Andreas Hochhaus; Philipp D le Coutre; Hagop M Kantarjian; Michele Baccarani; Philipp Erben; Andreas Reiter; Tracey McCulloch; Xiaolin Fan; Steven Novick; Francis J Giles
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-22       Impact factor: 4.553

10.  Organ-Specific Hypereosinophilic Syndrome Presenting as Eosinophilic Gastroenteritis.

Authors:  Aneesh Kumar; Asim Haider; Ayesha Siddiqa
Journal:  Cureus       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.